UniProt ID | UCHL3_HUMAN | |
---|---|---|
UniProt AC | P15374 | |
Protein Name | Ubiquitin carboxyl-terminal hydrolase isozyme L3 | |
Gene Name | UCHL3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 230 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Deubiquitinating enzyme (DUB) that controls levels of cellular ubiquitin through processing of ubiquitin precursors and ubiquitinated proteins. Thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of either ubiquitin or NEDD8. Has a 10-fold preference for Arg and Lys at position P3", and exhibits a preference towards 'Lys-48'-linked ubiquitin chains. Deubiquitinates ENAC in apical compartments, thereby regulating apical membrane recycling. Indirectly increases the phosphorylation of IGFIR, AKT and FOXO1 and promotes insulin-signaling and insulin-induced adipogenesis. Required for stress-response retinal, skeletal muscle and germ cell maintenance. May be involved in working memory. Can hydrolyze UBB(+1), a mutated form of ubiquitin which is not effectively degraded by the proteasome and is associated with neurogenerative disorders.. | |
Protein Sequence | MEGQRWLPLEANPEVTNQFLKQLGLHPNWQFVDVYGMDPELLSMVPRPVCAVLLLFPITEKYEVFRTEEEEKIKSQGQDVTSSVYFMKQTISNACGTIGLIHAIANNKDKMHFESGSTLKKFLEESVSMSPEERARYLENYDAIRVTHETSAHEGQTEAPSIDEKVDLHFIALVHVDGHLYELDGRKPFPINHGETSDETLLEDAIEVCKKFMERDPDELRFNAIALSAA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
43 | Phosphorylation | GMDPELLSMVPRPVC CCCHHHHCCCCCCCH | 30.29 | - | |
61 | Ubiquitination | LLFPITEKYEVFRTE HHEECCCCEEECCCH | 37.75 | - | |
75 | Phosphorylation | EEEEKIKSQGQDVTS HHHHHHHHCCCCHHH | 42.91 | 17525332 | |
81 | Phosphorylation | KSQGQDVTSSVYFMK HHCCCCHHHHHHHHH | 24.47 | 20068231 | |
82 | Phosphorylation | SQGQDVTSSVYFMKQ HCCCCHHHHHHHHHH | 20.04 | 20068231 | |
83 | Phosphorylation | QGQDVTSSVYFMKQT CCCCHHHHHHHHHHH | 16.09 | 28857561 | |
85 | Phosphorylation | QDVTSSVYFMKQTIS CCHHHHHHHHHHHHH | 10.41 | 20068231 | |
97 | Phosphorylation | TISNACGTIGLIHAI HHHHHHHHHHHHHHH | 16.26 | - | |
110 | Ubiquitination | AIANNKDKMHFESGS HHHCCCCCCCCCCCH | 35.56 | - | |
117 | Phosphorylation | KMHFESGSTLKKFLE CCCCCCCHHHHHHHH | 39.59 | 28857561 | |
118 | Phosphorylation | MHFESGSTLKKFLEE CCCCCCHHHHHHHHH | 46.23 | 28857561 | |
120 | Ubiquitination | FESGSTLKKFLEESV CCCCHHHHHHHHHHH | 41.38 | - | |
121 | Ubiquitination | ESGSTLKKFLEESVS CCCHHHHHHHHHHHC | 59.29 | 21890473 | |
126 | Phosphorylation | LKKFLEESVSMSPEE HHHHHHHHHCCCHHH | 15.32 | 23927012 | |
128 | Phosphorylation | KFLEESVSMSPEERA HHHHHHHCCCHHHHH | 23.87 | 29255136 | |
129 | Sulfoxidation | FLEESVSMSPEERAR HHHHHHCCCHHHHHH | 7.90 | 21406390 | |
130 | Phosphorylation | LEESVSMSPEERARY HHHHHCCCHHHHHHH | 22.96 | 29255136 | |
141 | Phosphorylation | RARYLENYDAIRVTH HHHHHHCCCEEEEEE | 9.44 | 28796482 | |
147 | Phosphorylation | NYDAIRVTHETSAHE CCCEEEEEECCCCCC | 12.26 | 28450419 | |
150 | Phosphorylation | AIRVTHETSAHEGQT EEEEEECCCCCCCCC | 24.49 | 28450419 | |
151 | Phosphorylation | IRVTHETSAHEGQTE EEEEECCCCCCCCCC | 25.33 | 28450419 | |
157 | Phosphorylation | TSAHEGQTEAPSIDE CCCCCCCCCCCCCCC | 45.00 | 29978859 | |
157 | O-linked_Glycosylation | TSAHEGQTEAPSIDE CCCCCCCCCCCCCCC | 45.00 | OGP | |
161 | Phosphorylation | EGQTEAPSIDEKVDL CCCCCCCCCCCCCCE | 50.12 | 25159151 | |
165 | Ubiquitination | EAPSIDEKVDLHFIA CCCCCCCCCCEEEEE | 36.98 | - | |
210 | Ubiquitination | EDAIEVCKKFMERDP HHHHHHHHHHHHCCH | 54.97 | 21890473 | |
211 | Ubiquitination | DAIEVCKKFMERDPD HHHHHHHHHHHCCHH | 44.83 | - | |
211 | Acetylation | DAIEVCKKFMERDPD HHHHHHHHHHHCCHH | 44.83 | 25953088 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
75 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UCHL3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UCHL3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND MASSSPECTROMETRY. |